Adempas Tablets and C1 esterase inhibitor recombinant Intravenous
Determining the interaction of Adempas Tablets and C1 esterase inhibitor recombinant Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: riociguat
Brand name: Adempas
Synonyms: Riociguat
Generic Name: C1 esterase inhibitor (human)
Brand name: Berinert, Cinryze, Haegarda, Ruconest
Synonyms: Complement C1 esterase inhibitor, C1 Inhibitor (Human)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Adempas Tablets-C1 esterase inhibitor, human Intravenous
- Adempas Tablets-C1 Inhibitor (Human)
- Adempas Tablets-C1 Inhibitor (Human) (Berinert)
- Adempas Tablets-C1 Inhibitor (Human) (Cinryze)
- Adempas Tablets-C1 Inhibitor (Human) (Haegarda)
- Adempas Tablets-C1 Inhibitor (Recombinant)
- C1 esterase inhibitor recombinant Intravenous-Adenocard
- C1 esterase inhibitor recombinant Intravenous-Adenoscan
- C1 esterase inhibitor recombinant Intravenous-Adenosine
- C1 esterase inhibitor recombinant Intravenous-Adenosine Intravenous
- C1 esterase inhibitor recombinant Intravenous-Adenovirus Type 4 and Type 7 Vaccine Live Oral
- C1 esterase inhibitor recombinant Intravenous-Adenovirus Vaccine